APA-referens

Gerstner, E., Izquierdo, D., Ou, Y., Emblem, K., Cai, X., Da, X., . . . Batchelor, T. (2015). NIMG-29 RADIOLABELED TEMOZOLOMIDE CAN MEASURE BEVACIZUMAB INDUCED VASCULAR MODULATION IN PATIENTS WITH RECURRENT GBM. Neuro Oncol.

Chicago-stil citat

Gerstner, Elizabeth, et al. "NIMG-29 RADIOLABELED TEMOZOLOMIDE CAN MEASURE BEVACIZUMAB INDUCED VASCULAR MODULATION IN PATIENTS WITH RECURRENT GBM." Neuro Oncol 2015.

MLA-referens

Gerstner, Elizabeth, et al. "NIMG-29 RADIOLABELED TEMOZOLOMIDE CAN MEASURE BEVACIZUMAB INDUCED VASCULAR MODULATION IN PATIENTS WITH RECURRENT GBM." Neuro Oncol 2015.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.